Reuters logo
4 months ago
BRIEF-Imprimis Pharmaceuticals acquires license to patented formulation for dry eye disease
April 6, 2017 / 1:10 PM / 4 months ago

BRIEF-Imprimis Pharmaceuticals acquires license to patented formulation for dry eye disease

1 Min Read

April 6 (Reuters) - Imprimis Pharmaceuticals Inc-

* Imprimis Pharmaceuticals acquires exclusive license to patented ophthalmic formulation for dry eye disease

* Imprimis Pharmaceuticals - under terms of agreement, imprimis will pay lindstrom an upfront fee, milestone payments, and royalty payments on product sales

* Imprimis Pharmaceuticals- under terms of agreement, imprimis will pay lindstrom upfront fee, milestone payments, royalty payments on product sales Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below